Atara Biotherapeutics (ATRA) Earnings Analysis
Atara Biotherapeutics (ATRA) next reports earnings on 2026-08-10, consensus EPS -0.315 USD. Last quarter (2026-05-14) it beat with EPS -0.29 USD vs -0.32953 USD est (+12%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -12.31.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ATRA next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.315 USD |
| Revenue estimate | 0.00B |
ATRA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.29 USD | -0.32953 USD | +12% | Beat |
| 2026-03-16 | -0.25 USD | -0.09 USD | -177.8% | Miss |
| 2025-11-12 | -0.32 USD | -0.83 USD | +61.4% | Beat |
| 2025-08-11 | 0.19 USD | -0.32 USD | +159.4% | Beat |
| 2025-05-15 | 3.5 USD | -3.07 USD | +214% | Beat |
| 2025-03-07 | -1.19 USD | -3.82 USD | +68.8% | Beat |
| 2024-08-12 | -3.1 USD | -1.25 USD | -148% | Miss |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
ATRA valuation and analyst view
| Trailing P/E | -12.31 |
|---|---|
| Trailing EPS | -0.67232 USD |
| Price / book | -3.07 |
| Dividend yield | 0.00% |
| Market cap | 0.08B |
| Analyst consensus | Hold (4 buy / 7 hold / 2 sell) |
| Avg price target | 13 USD |
Related research pages
Frequently asked questions
When is Atara Biotherapeutics (ATRA)'s next earnings date?
Atara Biotherapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.315 USD and revenue estimate of 0.00B.
Did ATRA beat earnings last quarter?
In its 2026-05-14 report, ATRA posted EPS of -0.29 USD versus a -0.32953 USD estimate — a beat of 12%.
What is ATRA's earnings track record?
Over the last 7 reported quarters with consensus data, ATRA beat estimates 5 times (71%).
What is ATRA's current P/E ratio and EPS?
ATRA trades at a trailing P/E of -12.31 on trailing EPS of -0.6723244087777857 USD.
What do analysts rate ATRA?
Analyst consensus is "Hold" across 13 ratings (0 strong buy, 4 buy, 7 hold, 2 sell, 0 strong sell). Average 12-month price target: 13 USD.